Search Tag: Charles River

ICU Management

2015 24 Jul

Charles River Laboratories International, Inc. (NYSE: CRL) has announced that it has completed the previously announced acquisition of Celsis International Ltd. for $212 million in cash, subject to certain post-closing working capital adjustments. The acquisition complements Charles River Endotoxin and Microbial Detection’s (EMD) position as a leading...Read more